ESLT: Terminating Coverage of Elbit Systems
Key Points We are terminating coverage of Elbit Systems (ESLT; previously rated Overweight) due to a change in research focus. Going forward, we will no longer maintain an investment rating ......
ALEMBIC GLOBAL ADVISORS
Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.We Are
EQUITY RESEARCH ADVISORS
2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
We Have
VALUABLE INSIGHT
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
We Offer
UNIQUE MARKET PERSPECTIVE
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Get in touch with us to learn more about working with Alembic Global Advisors.
LATEST NEWS
RESEARCH REPORTS
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
- December 11, 2024
- December 9, 2024
Westlake Corporation – Undemanding Estimates and a Likely Positive Valuation Re-Rating
Key Points Consensus 2025 earnings estimates undemanding, in our view. Macro trends could propel significant medium-term earnings growth Earnings power on the back of recent acquisitions still underappreciated. Valuation highly ......
- December 6, 2024
AVAV: Modest Bottom-Line & Target Price Reduction Post F2Q, but Reiterate Overweight Rating
Key Points We are maintaining our Overweight rating on shares of AVAV post the firm’s 2QFY25 earnings report earlier this week. The shares fell Thursday on margin headwinds in 2Q, ......
- December 3, 2024
TDG: Updating Forecast Post 4QFY24; Lowering Target Price & Maintaining Neutral Rating
Key Points We’re updating our forecast for TDG for the first time post its 4QFY24 earnings report. We’ve very modestly lowered our FY25/26 sales outlook on concerns over commercial aftermarket ......
- December 2, 2024
WWD: Updating Forecast and Raising Target Price Post F4Q but Maintaining Neutral Rating
Key Points We are maintaining our Neutral rating on shares of WWD as we update our forecast for the first time post the firm’s 4QFY24 earnings call last week. While ......
- December 2, 2024
Methanex – Higher Methanol Prices Sustainable; Strong Free Cash Flow Generation Underappreciated
Key Points Higher methanol price regime sustainable on the back of cost curve considerations and tightening supply/demand fundamentals Attractive free cash flow story evolving; company could cumulatively generate over 65% ......